DSRU attends ISoP Mid-Year Meeting

Some of the DSRU’s pharmacovigilance experts attended the mid year meeting of the International Society of Pharmacovigilance (ISoP) in Hatfield, UK, this week.

DSRU Director, Dr Linda Härmark, chaired a panel session on "Beyond Boundaries: Risk Management Lessons from Other Industries", while our Chief Medical Officer, Dr Miranda Davies, gave a presentation on "Patient Perspective in Benefit–Risk:Why, How, When

Linda, Miranda and PV specialist, Dr Alison Evans, also presented four posters which showcase some of our recent work:

• A Scoping Review of Case‑Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements. D. Cooper, MT. Ansari, T. Aurelius, A. Bobbins, S. Dhanda, C. Gravel4, M. Hauben, D. Morris, K. Morton, R. Platt, E. Van Puijenbroek, A. Yeomans, M. Davies
  
• Evaluation of Effectiveness of Additional Risk Minimisation Measures (aRMMs): Final Results from a UK Non-Interventional Post-Authorisation Safety Study (PASS). S. Dhanda, M. Davies, T. Aurelius, L. Härmark
  
• Enhanced Passive Safety Surveillance (EPSS) of Intranasal Influenza Vaccine (Fluenz® Tetra) in Children in England: Evaluation from Eight Seasons (2015/2016-2022/2023). S. Dhanda, D. Morris. L. Härmark
  
• Utilisation and safety of IV bolus diclofenac sodium (Akis®) for prevention or treatment of post-operative pain in UK secondary healthcare. A. Evans, K. Morton, T. Aurelius, D. Morris, J. Denyer, D. Roy, L. Härmark

The team enjoyed engaging discussions and the opportunity to hear about the latest progress in pharmacovigilance.